BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20373852)

  • 1. Microarray-based detection of CYP1A1, CYP2C9, CYP2C19, CYP2D6, GSTT1, GSTM1, MTHFR, MTRR, NQO1, NAT2, HLA-DQA1, and AB0 allele frequencies in native Russians.
    Gra O; Mityaeva O; Berdichevets I; Kozhekbaeva Z; Fesenko D; Kurbatova O; Goldenkova-Pavlova I; Nasedkina T
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):329-42. PubMed ID: 20373852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of drug-metabolizing enzymes CYP2C9, CYP2C19, CYP2D6, CYP1A1, NAT2 and of P-glycoprotein in a Russian population.
    Gaikovitch EA; Cascorbi I; Mrozikiewicz PM; Brockmöller J; Frötschl R; Köpke K; Gerloff T; Chernov JN; Roots I
    Eur J Clin Pharmacol; 2003 Aug; 59(4):303-12. PubMed ID: 12879168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients.
    Gra OA; Glotov AS; Nikitin EA; Glotov OS; Kuznetsova VE; Chudinov AV; Sudarikov AB; Nasedkina TV
    Am J Hematol; 2008 Apr; 83(4):279-87. PubMed ID: 18061941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of drug-metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population.
    Arvanitidis K; Ragia G; Iordanidou M; Kyriaki S; Xanthi A; Tavridou A; Manolopoulos VG
    Fundam Clin Pharmacol; 2007 Aug; 21(4):419-26. PubMed ID: 17635181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic polymorphism in GST, NAT2, and MTRR and susceptibility to childhood acute leukemia].
    Gra OA; Glotov AS; Kozhekbaeva Zhm; Makarova OV; Nasedkina TV
    Mol Biol (Mosk); 2008; 42(2):214-25. PubMed ID: 18610829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
    Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population.
    Hamdy SI; Hiratsuka M; Narahara K; El-Enany M; Moursi N; Ahmed MS; Mizugaki M
    Br J Clin Pharmacol; 2002 Jun; 53(6):596-603. PubMed ID: 12047484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population.
    Bozina N; Granić P; Lalić Z; Tramisak I; Lovrić M; Stavljenić-Rukavina A
    Croat Med J; 2003 Aug; 44(4):425-8. PubMed ID: 12950145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.
    Yousef AM; Bulatova NR; Newman W; Hakooz N; Ismail S; Qusa H; Zahran F; Anwar Ababneh N; Hasan F; Zaloom I; Khayat G; Al-Zmili R; Naffa R; Al-Diab O
    Mol Biol Rep; 2012 Oct; 39(10):9423-33. PubMed ID: 22722998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms in the Hmong population: implications for cancer etiology and survival.
    Kiffmeyer WR; Langer E; Davies SM; Envall J; Robison LL; Ross JA
    Cancer; 2004 Jan; 100(2):411-7. PubMed ID: 14716779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia.
    Bolufer P; Collado M; Barragán E; Cervera J; Calasanz MJ; Colomer D; Roman-Gómez J; Sanz MA
    Haematologica; 2007 Mar; 92(3):308-14. PubMed ID: 17339179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polymorphisms of drug-metabolizing enzymes genes in a Han Chinese population].
    Liu L; Yang L; Zhang YC; Ai XF; Wang JX; Xiao ZJ
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(38):2675-81. PubMed ID: 20137266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.
    Sachse C; Smith G; Wilkie MJ; Barrett JH; Waxman R; Sullivan F; Forman D; Bishop DT; Wolf CR;
    Carcinogenesis; 2002 Nov; 23(11):1839-49. PubMed ID: 12419832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.
    Siraj AK; Ibrahim M; Al-Rasheed M; Abubaker J; Bu R; Siddiqui SU; Al-Dayel F; Al-Sanea O; Al-Nuaim A; Uddin S; Al-Kuraya K
    BMC Med Genet; 2008 Jul; 9():61. PubMed ID: 18601742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
    Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
    Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.
    Scott SA; Edelmann L; Kornreich R; Erazo M; Desnick RJ
    Pharmacogenomics; 2007 Jul; 8(7):721-30. PubMed ID: 18240905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population.
    Halling J; Petersen MS; Damkier P; Nielsen F; Grandjean P; Weihe P; Lundgren S; Lundblad MS; Brøsen K
    Eur J Clin Pharmacol; 2005 Aug; 61(7):491-7. PubMed ID: 16025294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma.
    Khedhaier A; Hassen E; Bouaouina N; Gabbouj S; Ahmed SB; Chouchane L
    BMC Cancer; 2008 Apr; 8():109. PubMed ID: 18423013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allele and genotype frequencies of metabolic genes in Native Americans from Argentina and Paraguay.
    Bailliet G; Santos MR; Alfaro EL; Dipierri JE; Demarchi DA; Carnese FR; Bianchi NO
    Mutat Res; 2007 Mar; 627(2):171-7. PubMed ID: 17194620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.